observational
    2025

    Biofilm Disruption Enhances Antimicrobial Therapy for Small Intestinal Bacterial Overgrowth and Intestinal Methanogen Overgrowth

    Ruscio M, Guard G, O'Dwyer D, Darville R, Klopf H, Abbott R, et al.

    Published in Cureus, Vol. 17 (12), pp. e99116

    Methodology

    Retrospective chart review of 13 patients with SIBO, intestinal methanogen overgrowth (IMO) or both, previously randomised to an 8-week herbal antimicrobial protocol alone (n=5) or with biofilm disruptors (n=8). The first-month formula supplied 60 mg oregano oil per capsule, taken as 4 capsules twice daily.

    Key Findings

    Hydrogen fell more with biofilm disruptors (-30.75 vs -11.40 ppm), as did methane (-26.38 vs -2.00 ppm). Of 7 hydrogen-positive patients, 5 cleared SIBO (3 of 5 with biofilm agents, 2 of 2 without; not significant); no patient cleared methane overgrowth (IMO).

    Conclusions

    Adding a biofilm disruptor was associated with larger falls in breath gases; larger controlled studies are needed.

    Limitations

    Very small, retrospective, no arm without herbs, and the lead author owns the company that makes the formulas tested.

    Supplements Studied

    herbal antimicrobials are emerging as alternatives to rifaximin

    Related Health Concerns

    Study Details

    Year:2025
    Sample Size:13
    Duration:8 weeks
    Quality Score:2/10

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.